52 related articles for article (PubMed ID: 38673901)
41. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
[TBL] [Abstract][Full Text] [Related]
42. Technology of irreversible electroporation and review of its clinical data on liver cancers.
Cohen EI; Field D; Lynskey GE; Kim AY
Expert Rev Med Devices; 2018 Feb; 15(2):99-106. PubMed ID: 29307242
[TBL] [Abstract][Full Text] [Related]
43. Niche Applications of Irreversible Electroporation.
Bhatia SS; Arya R; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
[TBL] [Abstract][Full Text] [Related]
44. Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method.
Gajewska-Naryniecka A; Szwedowicz U; Łapińska Z; Rudno-Rudzińska J; Kielan W; Kulbacka J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901812
[TBL] [Abstract][Full Text] [Related]
45. Irreversible Electroporation for Colorectal Liver Metastases.
Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
[TBL] [Abstract][Full Text] [Related]
46. Irreversible electroporation: state of the art.
Wagstaff PG; Buijs M; van den Bos W; de Bruin DM; Zondervan PJ; de la Rosette JJ; Laguna Pes MP
Onco Targets Ther; 2016; 9():2437-46. PubMed ID: 27217767
[TBL] [Abstract][Full Text] [Related]
47. The Induction of Combined Hyperthermal Ablation Effect of Irreversible Electroporation with Polydopamine Nanoparticle-Coated Electrodes.
Jeon SM; Davaa E; Jenjob R; Pechyen C; Natphopsuk S; Jeong S; Yoo HJ; Yang SG
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673901
[TBL] [Abstract][Full Text] [Related]
48. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
Front Immunol; 2021; 12():811726. PubMed ID: 35069599
[TBL] [Abstract][Full Text] [Related]
49. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
[TBL] [Abstract][Full Text] [Related]
50. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
51. Introduction to Irreversible Electroporation--Principles and Techniques.
Thomson KR; Kavnoudias H; Neal RE
Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
[TBL] [Abstract][Full Text] [Related]
52. [Research Progress of Catheter-based Irreversible Electroporation for Tissue Ablation].
Zhou Y; Han X; Ren F; Li Q; Chen X; Chu D; Wu R; Lyu Y
Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):172-178. PubMed ID: 32400994
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
